Skip to main content
. 2020 Jul 9;11:970. doi: 10.3389/fphar.2020.00970

Figure 3.

Figure 3

Price ratio of biosimilar infliximab in 4 countries. The price ratio is defined as the price of biosimilar infliximab (numerator) with reference to the price of originator infliximab (denominator) in each period.